FDA official logo
GSRS logo
PFDA official logo

OLANZAPINE

  • UNII: N7U69T4SZR
  • Formula: C17H20N4S
  • Preferred Substance Name: OLANZAPINE
  • InChIKey: KVWDHTXUZHCGIO-UHFFFAOYSA-N

  • 132539-06-1
  • 10H-THIENO(2,3-B)(1,5)BENZODIAZEPINE, 2-METHYL-4-(4-METHYL-1-PIPERAZINYL)-
  • 2-METHYL-4-(4-METHYL-1-PIPERAZINYL)-10H-THIENO(2,3-B)(1,5)BENZODIAZEPINE
  • LY170053
  • LY-170053
  • LYBALVI COMPONENT OLANZAPINE
  • OLANSEK
  • OLANZAPINE [EMA EPAR]
  • OLANZAPINE [EP MONOGRAPH]
  • OLANZAPINE [INN]
  • OLANZAPINE [JAN]
  • OLANZAPINE [MART.]
  • OLANZAPINE [MI]
  • OLANZAPINE [ORANGE BOOK]
  • OLANZAPINE [USAN]
  • OLANZAPINE [USP MONOGRAPH]
  • OLANZAPINE [USP-RS]
  • OLANZAPINE [VANDF]
  • OLANZAPINE [WHO-DD]
  • OLANZAPINE APOTEX
  • OLANZAPINE CIPLA
  • OLANZAPINE COMPONENT OF LYBALVI
  • OLANZAPINE COMPONENT OF SYMBYAX
  • OLANZAPINE GLENMARK
  • OLANZAPINE GLENMARK EUROPE
  • OLANZAPINE MYLAN
  • OLANZAPINE TEVA
  • OLAZAX
  • OLAZAX DISPERZI
  • SYMBYAX COMPONENT OLANZAPINE
  • ZALASTA
  • ZYPREXA
  • ZYPREXA VELOTAB

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.